The Role of Serum Adiponectin for Outcome Prediction in Patients with Dilated Cardiomyopathy and Advanced Heart Failure

Table 5

Baseline characteristics in patient groups with high and low APN value.

Parameters	APN < 14,2 μg/ml	APN ≥ 14.2 μg/ml	value
Sex	M: 23 (85.2%); F: 4 (14.8%)	M: 21 (75%); F: 7 (25%)	0.345
NYHA class	I + II: 4 (15.4%); III: 20 (76.9%); IV: 2 (7.7%)	I + II: 2 (7.4%); III: 16 (59.3%); IV: 9 (33.3%)	0.061
Age (years)	48.19 ± 8.29	46.96 ± 12.89	0.679
(kg/m^2)	27.92 ± 5.70	24.41 ± 9.00	0.168
GFR (ml/min)	111.78 ± 27.66	110.70 ± 36.64	0.907
Systolic BP (mmHg)	121 ± 21	112 ± 20	<0.0002
Diastolic BP (mmHg)	75 ± 10	80 ± 10	0.647
Serum glucose (mmol/l)	5.38 ± 1.07	5.38 ± 2.39	0.913
(pg/ml)	113.8 ± 694.35	1397 ± 2338.5	<0,001
IL- (pg/ml)	2,01 ± 4.27	3,18 ± 6.08	0.245
TNF- (pg/ml)	7.54 ± 3.18	9.09 ± 2.54	0.029
(ug/ml)	3.05 ± 6.53	6.15 ± 13.23	0.252
(pg/ml)	23.55 ± 28.28	31,00 ± 31.76	0.368
LV DD (cm)	6.80 ± 0,80	6.95 ± 0.94	0.548
EF (%)	27.15 ± 9.60	26.22 ± 9.50	0.493
Average global strain (%)	−9.26 ± 3.42	−7.09 ± 3.38	0.051
(cells/mm^2)	10 ± 5	11 ± 10	0.364
(cells/mm^2)	6 ± 3	7 ± 5	0.493
(cells/mm^2)	5 ± 2	5 ± 2	0.769
Mean (mmHg)	11.00 ± 8.00	11.50 ± 11.50	0.099
Mean (mmHg)	25.5 ± 13.00	37.0 ± 19.00	0.036
Mean PCWP (mmHg)	19.50 ± 8.26	24.12 ± 8.73	0.083
CO (l/min	4.9 ± 2.77	3.9 ± 1.32	0.035
CI (l/min/m^2	2.29 ± 1.12	2.05 ± 0.89	0.131

BMI: body mass index, GFR: glomerular filtration rate, APN: adiponectin, BNP: brain natriuretic peptide, IL-6: interleukin-6, TNF-α: tumor necrosis factor α, CRP: C reactive protein, hsTnT: high sensitivity troponin T, LVEDD: left ventricle diastolic diameter, LVEF: left ventricle ejection fraction, CD3+: T cell receptor, CD45ro+: memory T cell receptor, CD68+: monocyte/macrophage receptor, RAP: right atrial pressure, PAP: pulmonary artery pressure, PCWP: pulmonary capillary wedge pressure, CO: cardiac output, and CI: cardiac index. Data presented as median ± interquartile range. Significant at the level 0.05 (2-tailed).